ANGN

Analyst Sentiment

Wall St. Consensus
Hold
3 analysts·Low coverage
58
Score
1 Buy (33%)2 Hold (67%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
133%
Hold
267%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$1.50
+50.0%
Consensus
$1.50
+50.0%
Bull
$1.50
+50.0%
12-Month Target Range3 analysts
$1.50$1.50$1.50
Current $1.00Consensus
Current Price
$1.00
Upside to Consensus
$0.50

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

No analyst estimates available

Earnings Surprises

Recent Analyst Actions

Jun 30, 2022Stifel Nicolaus
Angion Biomedica downgraded to Hold from Buy at Stifel
Target:$1.50
-12.3%from $1.71
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.